Global Traveller’s Diarrhoea Treatment Market Report and Forecast 2023-2031
Global Traveller’s Diarrhoea Treatment Market Outlook:
The global traveller’s diarrhoea treatment market size is likely to be driven by the increasing demand for natural and clean label ingredients across the globe. The market value is anticipated to grow at a CAGR of 6% during the forecast period of 2023-2031.
Traveller’s Diarrhoea: Introduction
Traveller's diarrhoea is a common health concern for individuals traveling to different regions and countries. It is characterized by the onset of loose and frequent bowel movements, often accompanied by abdominal cramps, nausea, and vomiting. The condition is primarily caused by consuming contaminated food or water, typically due to bacterial, viral, or parasitic infections.
Key Trends in the Traveller’s Diarrhoea Treatment Market
Some key trends involved in the traveller’s diarrhoea treatment market are as follows:
Increasing Travel Activity: The rise in global travel and tourism has contributed to a higher incidence of traveller's diarrhoea. As more people travel to various destinations, especially to regions with different hygiene and sanitation standards, the risk of exposure to contaminated food and water increases.
Focus on Prevention: There is a growing emphasis on preventive measures to reduce the risk of traveller's diarrhoea. This includes educating travelers about safe food and water practices, promoting proper hygiene, and encouraging the use of water purification methods and food hygiene practices.
Improved Diagnostics: Diagnostic methods for traveller's diarrhoea have seen advancements in recent years. Rapid diagnostic tests are becoming more accessible, allowing for quick identification of the causative pathogens. These tests aid in targeted treatment and appropriate management of the condition.
Traveller’s Diarrhoea Treatment Market Segmentations
Market Breakup by Drug Type
Oral Rehydration Therapy (ORS)
Antidiarrhoeal Agents
Antibiotics
Azithromycin
Ciprofloxacin
Quinolones
Rifaximin
Others
Vaccine/Prophylactics
Others
Market Breakup by Pathogen
Bacteria
Viruses
Protozoa
Others
Market Breakup by Age
Adult
Children
Market by Route of Administration
Oral
Parenteral
Market by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Market Breakup by Region
North America
United States of America
Canada
Europe
United Kingdom
Germany
France
Italy
Others
Asia Pacific
China
Japan
India
ASEAN
Australia
Others
Latin America
Brazil
Argentina
Mexico
Others
Middle East and Africa
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Others
Traveller’s Diarrhoea Treatment Market Scenario
The market for traveller's diarrhoea management and prevention is driven by the increasing global travel activity and the rising awareness of health risks associated with travelling to different regions. Traveller's diarrhoea is a common concern for both leisure and business travelers, and the market offers various products and services to address this issue.
The market is composed of several key players, including pharmaceutical companies, travel health clinics, healthcare providers, and manufacturers of diagnostic tests, medications, and preventive measures. These entities play a crucial role in providing solutions and guidance to travelers to minimize the risk of traveller's diarrhoea.
The market is driven by the increasing demand for travel health services, as travelers prioritize their health and seek professional guidance for a safe and healthy travel experience. Travel clinics, healthcare providers, and online platforms have expanded their services to cater to this growing demand, offering comprehensive solutions and personalized recommendations.
Overall, the market for traveller's diarrhoea management and prevention is dynamic and evolving, driven by increasing travel activity and the need for safe and healthy travel experiences. The market offers a range of products and services to address the specific needs of travelers, with a focus on prevention, treatment, and digital health solutions.
Traveller’s Diarrhoea Treatment Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Bausch Health Companies Inc.
COSMO Pharmaceuticals
Immuron Ltd.
Sanofi SA
Bayer AG
Merck & Co., Inc
Johnson & Johnson Services, Inc.
Novartis AG
Basilea Pharmaceutica Ltd
Eli Lilly and Company
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Traveller’s Diarrhoea Overview
- 3.1 Guidelines and Stages
- 3.2 Pathophysiology
- 3.3 Screening and Diagnosis
- 3.4 Treatment Pathway
- 4 Patient Profile
- 4.1 Patient Profile Overview
- 4.2 Patient Psychology and Emotional Impact Factors
- 4.3 Risk Assessment and Treatment Success Rate
- 5 Traveller’s Diarrhoea Epidemiology Analysis
- 5.1 Epidemiology Overview (2016-2031)
- 5.2 North America Traveller’s Diarrhoea Epidemiology (2016-2031)
- 5.3 Europe Traveller’s Diarrhoea Epidemiology (2016-2031)
- 5.4 Asia-Pacific Traveller’s Diarrhoea Epidemiology (2016-2031)
- 5.5 Latin America Traveller’s Diarrhoea Epidemiology (2016-2031)
- 5.6 Middle East & Africa Traveller’s Diarrhoea Epidemiology (2016-2031)
- 6 Global Traveller’s Diarrhoea Treatment Market Overview
- 6.1 Global Traveller’s Diarrhoea Treatment Market Historical Value (2016-2022)
- 6.2 Global Traveller’s Diarrhoea Treatment Market Forecast Value (2023-2031)
- 7 Global Traveller’s Diarrhoea Treatment Market Landscape
- 7.1 Traveller’s Diarrhoea Treatment: Developers Landscape
- 7.1.1 Analysis by Year of Establishment
- 7.1.2 Analysis by Company Size
- 7.1.3 Analysis by Region
- 7.2 Traveller’s Diarrhoea Treatment: Product Landscape
- 7.2.1 Analysis by Drug Type
- 7.2.2 Analysis by Pathogen
- 7.2.3 Analysis by Age
- 7.2.4 Analysis by Route of Administration
- 7.2.5 Analysis by Distribution Channel
- 8 Traveller’s Diarrhoea Treatment Challenges and Unmet Needs
- 8.1 Treatment Pathway Challenges
- 8.2 Compliance and Drop-Out Analysis
- 8.3 Awareness and Prevention Gaps
- 9 Cost of Treatment
- 10 Global Traveller’s Diarrhoea Treatment Market Dynamics
- 10.1 Market Drivers and Constraints
- 10.2 SWOT Analysis
- 10.3 Porter’s Five Forces Model
- 10.4 Key Demand Indicators
- 10.5 Key Price Indicators
- 10.6 Industry Events, Initiatives, and Trends
- 10.7 Value Chain Analysis
- 11 Global Traveller’s Diarrhoea Treatment Market Segmentation
- 11.1 Global Traveller’s Diarrhoea Treatment Market by Drug Type
- 11.1.1 Market Overview
- 11.1.2 Oral Rehydration Therapy (ORS)
- 11.1.3 Antidiarrhoeal Agents
- 11.1.3.1 Antibiotics
- 11.1.3.2 Azithromycin
- 11.1.3.3 Ciprofloxacin
- 11.1.3.4 Quinolones
- 11.1.3.5 Rifaximin
- 11.1.3.6 Others
- 11.1.4 Vaccine/Prophylactics
- 11.1.5 Others
- 11.2 Global Traveller’s Diarrhoea Treatment Market by Pathogen
- 11.2.1 Market Overview
- 11.2.2 Bacteria
- 11.2.3 Viruses
- 11.2.4 Protozoa
- 11.2.5 Others
- 11.3 Global Traveller’s Diarrhoea Treatment Market by Age
- 11.3.1 Market Overview
- 11.3.2 Adult
- 11.3.3 Children
- 11.4 Global Traveller’s Diarrhoea Treatment Market by Route of Administration
- 11.4.1 Market Overview
- 11.4.2 Oral
- 11.4.3 Parenteral
- 11.5 Global Traveller’s Diarrhoea Treatment Market by Distribution Channel
- 11.5.1 Market Overview
- 11.5.2 Hospital Pharmacies
- 11.5.3 Retail Pharmacies
- 11.5.4 Online Pharmacies
- 11.5.5 Others
- 11.6 Global Traveller’s Diarrhoea Treatment Market by Region
- 11.6.1 Market Overview
- 11.6.2 North America
- 11.6.3 Europe
- 11.6.4 Asia Pacific
- 11.6.5 Latin America
- 11.6.6 Middle East and Africa
- 12 North America Traveller’s Diarrhoea Treatment Market
- 12.1 Market Share by Country
- 12.2 United States of America
- 12.3 Canada
- 13 Europe Traveller’s Diarrhoea Treatment Market
- 13.1 Market Share by Country
- 13.2 United Kingdom
- 13.3 Germany
- 13.4 France
- 13.5 Italy
- 13.6 Others
- 14 Asia Pacific Traveller’s Diarrhoea Treatment Market
- 14.1 Market Share by Country
- 14.2 China
- 14.3 Japan
- 14.4 India
- 14.5 ASEAN
- 14.6 Australia
- 14.7 Others
- 15 Latin America Traveller’s Diarrhoea Treatment Market
- 15.1 Market Share by Country
- 15.2 Brazil
- 15.3 Argentina
- 15.4 Mexico
- 15.5 Others
- 16 Middle East and Africa Traveller’s Diarrhoea Treatment Market
- 16.1 Market Share by Country
- 16.2 Saudi Arabia
- 16.3 United Arab Emirates
- 16.4 Nigeria
- 16.5 South Africa
- 16.6 Others
- 17 Regulatory Framework
- 17.1 Regulatory Overview
- 17.1.1 US FDA
- 17.1.2 EU EMA
- 17.1.3 INDIA CDSCO
- 17.1.4 JAPAN PMDA
- 17.1.5 Others
- 18 Patent Analysis
- 18.1 Analysis by Type of Patent
- 18.2 Analysis by Publication year
- 18.3 Analysis by Issuing Authority
- 18.4 Analysis by Patent Age
- 18.5 Analysis by CPC Analysis
- 18.6 Analysis by Patent Valuation
- 18.7 Analysis by Key Players
- 19 Grants Analysis
- 19.1 Analysis by year
- 19.2 Analysis by Amount Awarded
- 19.3 Analysis by Issuing Authority
- 19.4 Analysis by Grant Application
- 19.5 Analysis by Funding Institute
- 19.6 Analysis by NIH Departments
- 19.7 Analysis by Recipient Organization
- 20 Clinical Trials Analysis
- 20.1 Analysis by Trial Registration Year
- 20.2 Analysis by Trial Status
- 20.3 Analysis by Trial Phase
- 20.4 Analysis by Therapeutic Area
- 20.5 Analysis by Geography
- 21 Funding and Investment Analysis
- 21.1 Analysis by Funding Instances
- 21.2 Analysis by Type of Funding
- 21.3 Analysis by Funding Amount
- 21.4 Analysis by Leading Players
- 21.5 Analysis by Leading Investors
- 21.6 Analysis by Geography
- 22 Partnership and Collaborations Analysis
- 22.1 Analysis by Partnership Instances
- 22.2 Analysis by Type of Partnership
- 22.3 Analysis by Leading Players
- 22.4 Analysis by Geography
- 23 Supplier Landscape
- 23.1 Bausch Health Companies Inc.
- 23.1.1 Financial Analysis
- 23.1.2 Product Portfolio
- 23.1.3 Demographic Reach and Achievements
- 23.1.4 Mergers and Acquisitions
- 23.1.5 Certifications
- 23.2 COSMO Pharmaceuticals
- 23.2.1 Financial Analysis
- 23.2.2 Product Portfolio
- 23.2.3 Demographic Reach and Achievements
- 23.2.4 Mergers and Acquisitions
- 23.2.5 Certifications
- 23.3 Immuron Ltd.
- 23.3.1 Financial Analysis
- 23.3.2 Product Portfolio
- 23.3.3 Demographic Reach and Achievements
- 23.3.4 Mergers and Acquisitions
- 23.3.5 Certifications
- 23.4 Sanofi SA
- 23.4.1 Financial Analysis
- 23.4.2 Product Portfolio
- 23.4.3 Demographic Reach and Achievements
- 23.4.4 Mergers and Acquisitions
- 23.4.5 Certifications
- 23.5 Bayer AG
- 23.5.1 Financial Analysis
- 23.5.2 Product Portfolio
- 23.5.3 Demographic Reach and Achievements
- 23.5.4 Mergers and Acquisitions
- 23.5.5 Certifications
- 23.6 Merck & Co., Inc
- 23.6.1 Financial Analysis
- 23.6.2 Product Portfolio
- 23.6.3 Demographic Reach and Achievements
- 23.6.4 Mergers and Acquisitions
- 23.6.5 Certifications
- 23.7 Johnson & Johnson Services, Inc.
- 23.7.1 Financial Analysis
- 23.7.2 Product Portfolio
- 23.7.3 Demographic Reach and Achievements
- 23.7.4 Mergers and Acquisitions
- 23.7.5 Certifications
- 23.8 Novartis AG
- 23.8.1 Financial Analysis
- 23.8.2 Product Portfolio
- 23.8.3 Demographic Reach and Achievements
- 23.8.4 Mergers and Acquisitions
- 23.8.5 Certifications
- 23.9 Basilea Pharmaceutica Ltd
- 23.9.1 Financial Analysis
- 23.9.2 Product Portfolio
- 23.9.3 Demographic Reach and Achievements
- 23.9.4 Mergers and Acquisitions
- 23.9.5 Certifications
- 23.10 Eli Lilly and Company
- 23.10.1 Financial Analysis
- 23.10.2 Product Portfolio
- 23.10.3 Demographic Reach and Achievements
- 23.10.4 Mergers and Acquisitions
- 23.10.5 Certifications
- 24 Traveller’s Diarrhoea Treatment - Distribution Model (Additional Insight)
- 24.1 Overview
- 24.2 Potential Distributors
- 24.3 Key Parameters for Distribution Partner Assessment
- 25 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 26 Company Competitiveness Analysis (Additional Insight)
- 26.1 Very Small Companies
- 26.2 Small Companies
- 26.3 Mid-Sized Companies
- 26.4 Large Companies
- 26.5 Very Large Companies
- 27 Payment Methods (Additional Insight)
- 27.1 Government Funded
- 27.2 Private Insurance
- 27.3 Out-of-Pocket
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook